BI 1356225
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BI 1356225, covering 2026-03-04 to 2026-03-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Test Whether BI 1356225 Improves Impulsive Behavior in People With Opioid Use Disorder Who Are Taking Buprenorphine [Phase 1]